Chitosan Nanoparticles for Intranasal Drug Delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology

Background:

• Intranasal drug delivery offers a non-invasive route for systemic and central nervous system (CNS) administration.
• Chitosan, a natural polysaccharide, possesses unique properties suitable for nanoparticle formulation.
• Effective drug delivery to the brain remains a significant challenge due to the blood-brain barrier (BBB).

Purpose of the Study:

• To explore nanostructured chitosan as a platform for intranasal drug delivery.
• To evaluate its potential in treating neurodegenerative diseases, psychiatric disorders, pain, and diabetes.
• To assess its efficacy in enhancing vaccine delivery and reducing side effects.

Main Methods:

• Formulation of chitosan nanoparticles for drug encapsulation.
• In vitro and in vivo studies to assess nanoparticle characteristics and drug transport.
• Evaluation of therapeutic efficacy across various disease models.

Main Results:

• Chitosan nanoparticles demonstrated enhanced drug transport across the BBB.
• Improved bioavailability and reduced systemic side effects were observed.
• Positive outcomes in preclinical models for targeted therapeutic applications.

Conclusions:

• Nanostructured chitosan holds significant promise for advanced intranasal drug delivery systems.
• Addressing challenges in scalability and regulatory approval is crucial for clinical translation.
• Future development requires interdisciplinary collaboration and innovative nanoparticle design.